Back to Search Start Over

Effect of a pneumococcal whole cell vaccine on influenza A-induced pneumococcal otitis media in infant mice.

Authors :
Manning J
Dunne EM
Wang N
Pedersen JS
Ogier JM
Burt RA
Mulholland EK
Robins-Browne RM
Malley R
Wijburg OL
Satzke C
Source :
Vaccine [Vaccine] 2019 Jun 06; Vol. 37 (26), pp. 3495-3504. Date of Electronic Publication: 2019 May 15.
Publication Year :
2019

Abstract

The pneumococcus remains a common cause of otitis media (OM) despite the widespread introduction of pneumococcal conjugate vaccines. In mice, a pneumococcal whole cell vaccine (WCV) induces serotype-independent protection against pneumococcal colonisation and invasive disease via T <subscript>H</subscript> 17- and antibody-mediated immunity, respectively. We investigated the effect of WCV on influenza A-induced pneumococcal OM in an infant mouse model. C57BL/6 mice were immunised subcutaneously with a single dose of WCV or adjuvant at 6 days of age, infected with pneumococci (EF3030 [serotype 19F] or PMP1106 [16F]) at 12 days of age, and given influenza A virus (A/Udorn/72/307 [H3N2], IAV) at 18 days of age to induce pneumococcal OM. Pneumococcal density in middle ear and nasopharyngeal tissues was determined 6 and 12 days post-virus. Experiments were repeated in antibody (B6.μMT <superscript>-/-</superscript> )- and CD4 <superscript>+</superscript> T-cell-deficient mice to investigate the immune responses involved. A single dose of WCV did not prevent the development of pneumococcal OM, nor accelerate pneumococcal clearance compared with mice receiving adjuvant alone. However, WCV reduced the density of EF3030 in the middle ear at 6 days post-viral infection (p = 0.022), and the density of both isolates in the nasopharynx at 12 days post-viral infection (EF3030, p = 0.035; PMP1106, p = 0.011), compared with adjuvant alone. The reduction in density in the middle ear required antibodies and CD4 <superscript>+</superscript> T cells: WCV did not reduce EF3030 middle ear density in B6.μMT <superscript>-/-</superscript> mice (p = 0.35) nor in wild-type mice given anti-CD4 monoclonal antibody before and after IAV inoculation (p = 0.91); and WCV-immunised CD4 <superscript>+</superscript> T cell-deficient GK1.5 mice had higher levels of EF3030 in the middle ear than their adjuvant-immunised counterparts (p = 0.044). A single subcutaneous dose of WCV reduced pneumococcal density in the middle ears of co-infected mice in one of two strains tested, but did not prevent OM from occurring in this animal model.<br /> (Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.)

Details

Language :
English
ISSN :
1873-2518
Volume :
37
Issue :
26
Database :
MEDLINE
Journal :
Vaccine
Publication Type :
Academic Journal
Accession number :
31103366
Full Text :
https://doi.org/10.1016/j.vaccine.2019.03.013